Late Breaking Original Research
Tuesday, November 14, 2023
08:30 AM–10:00 AM
Abstract
Introduction: Black persons comprise 13% of the U.S. population but represent 32% of people with kidney failure. Medication-related disparities may contribute to these disparities. New classes of medications show promise in reducing chronic kidney disease (CKD) progression. Including patients’ perspectives are essential to ensure optimal medication and equitable health outcomes.
Research Question or Hypothesis: (1) What are patients’ concerns or challenges with medications? (2) What do they want to know about their medications? (3) What motivates them to learn about their medical conditions and medications? (4) How can patients and healthcare professionals build trusting relationships?
Study Design: We used a qualitative design with focus group methodology.
Methods: Facilitator guides were developed based on literature review with input from community stakeholders. Participants that self-identified as African American or Black were recruited nationally and represented all stages of chronic kidney disease. Patient focus groups were facilitated by the principal investigator or graduate research assistant and patient research team members. Interviews were transcribed verbatim, and inductive thematic analysis procedures were followed. NVivo© qualitative data analysis software facilitated analysis. Principles of rigor for qualitative research outlined by Lincoln and Guba were maintained.
Results: Four overarching themes and associated sub-themes emerged: (1) meet patients where they are, (2) the patient journey with medications, (3) significant interactions with healthcare professionals, and (4) recommendations for healthcare professionals. Strategies were compiled for pharmacists and healthcare professionals to effectively engage and empower Black persons with CKD to participate in shared decision-making and their care.
Conclusion: Awareness of biases and historical experiences, attention to patient needs and priorities, and using strategies to overcome barriers and empower patients are anticipated to reduce medication-related disparities and improve this population’s health outcomes.
Presenting Author
Lisa Hillman Pharm.D., Ph.D.University of Minnesota
Authors
Ayan Mohamed B.S.
University of Minnesota College of Pharmacy
Shukri Mohamed B.S.
University of Minnesota College of Pharmacy
Curtis Warfield M.S.
AKHOMM
Glenda Roberts B.S.
Kidney Research Institute
Wendy St. Peter Pharm.D.
University of Minnesota College of Pharmacy